Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 5,827 shares at $6.76 ($40K) on 2021-01-07, disclosed to the SEC on 2021-01-11.
Open-market sale of $40k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 2,697 | $18K | 45.4% |
| 2 | $7.00 | 3,130 | $22K | 54.6% |
| Total | $6.89 avg | 5,827 | $40K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $536K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |